Mylan Rejects $40 Billion Teva Takeover Offer, Calls Stock 'Low-Quality' |
| April 28, 2015 | April 2015 Bond Updates |
|
Generic drug-maker Mylan doesn't appear to be very interested in Teva Pharmaceuticals $40 billion takeover offer. |
| View more at: http://www.forbes.com/sites/antoinegara/2015/04/27/mylan-rejects-40-billion-teva-takeover-offer-calls-stock-low-quality/ |
| Related News |
|